Found 0 matching trials
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
PHASE2Multicenter, open-label, non-comparative study to evaluate the pharmacokine...
Location
University of California San Francisco UCSF
Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
PHASE2The purpose of this study is to determine if LCI699, thorough reductions in...
Location
Novartis Investigator Site
A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension
PHASE2This study determined the maximum dose of LCI6999 with respect to effect on...
Location
Impact Clinical Trials
A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function
PHASE1To characterize the pharmacokinetics of LCI699 following a single oral dose...
Location
Novartis Investigative Site
Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
PHASE2The purpose of this study is the evaluation of long-term safety of osilodro...
Location
University of Colorado
Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome
N/AThis is a multi-centre, observational, non-comparative, retrospective cohor...
Location
Hôpital Haut-Lévèque
Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
PHASE4To characterize the impact of Isturisa on clinical features and comorbiditi...
Location
Johns Hopkins University School of Medicine
Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome
PHASE4The purpose of this study is to continue the evaluation of long-term safety...
Location
University of Alberta Hospital - Alberta Diabetes Institute
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
PHASE2The purpose of this study is to evaluate the safety and tolerability of 1 m...
A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function
PHASE1To assess the pharmacokinetics of a single oral dose of osilodrostat (LCI69...
Location
University of Miami / Clinical Research Services, Inc. Boynton Beach